F19.22
Other psychoactive substance dependence with intoxication
Clinical Classification Guidelines
Excludes Type 1
- other psychoactive substance dependence with withdrawal (F19.23-)
Medical Intelligence & Overview
ICD-10 code F19.22 refers to a specific medical diagnosis characterized by dependence on psychoactive substances other than alcohol or opioids, accompanied by intoxication. This condition involves a behavioral pattern where an individual compulsively seeks and uses psychoactive substances, leading to intoxication episodes despite potential negative consequences. It can significantly impact an individual's mental, physical, and social well-being. Recognizing this condition is crucial for appropriate management and intervention, although treatment approaches should always be overseen by healthcare professionals.
Causes & Symptoms
Clinical Causes: Repeated use of psychoactive substances such as stimulants, hallucinogens, sedatives, or other chemicals Psychological factors like stress, anxiety, or depression that may lead to substance use as a coping mechanism Genetic predispositions affecting susceptibility to dependence Environmental influences, including peer pressure or availability of substances History of mental health disorders that can increase vulnerability
Key Symptoms: Craving or a strong desire to use the substance Difficulty controlling or reducing substance intake Neglecting responsibilities and activities in favor of drug use Taking larger amounts or using more frequently than intended Experiencing withdrawal symptoms when not using the substance Continued use despite awareness of negative health, social, or legal consequences Impaired cognitive or motor functions during intoxication episodes Changes in mood, perception, and behavior, such as paranoia or hallucinations
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a comprehensive clinical assessment, including patient history, substance use patterns, and physical and mental health evaluations. Healthcare providers may use standardized screening tools to determine dependence patterns. Laboratory tests, such as blood or urine analyses, can support the diagnosis by detecting the presence of specific substances. A psychologist or psychiatrist might assess for co-occurring mental health conditions that could influence treatment planning.
Treatment Protocols: Detoxification programs to safely manage withdrawal symptoms under medical supervision Psychotherapy approaches like cognitive-behavioral therapy (CBT) to address behavioral patterns and triggers Medication-assisted treatments when appropriate, especially if co-occurring mental health issues are present Support groups and counseling to foster recovery and prevent relapse Educational interventions to inform about the risks of substance dependence Developing a strong support network including family and friends
Clinical Advice & FAQs
Billing Guidance
Is F19.22 a billable ICD-10 code?
Yes, F19.22 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F19.22?
Clinical documentation must specify the nature of Other psychoactive substance dependence with intoxication and any associated comorbidities for accurate reporting.
Cite this Clinical Reference